Clinical Trials Logo

Clinical Trial Summary

The validity (by alcohol burning and gas infusions) and reliability (day-to-day variability in healthy subjects) of six metabolic carts will be compared.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04995211
Study type Observational
Source Pennington Biomedical Research Center
Contact
Status Completed
Phase
Start date July 22, 2021
Completion date February 7, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05864833 - METabolism After Orthopedic Surgery
Completed NCT02235961 - Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects Phase 1
Completed NCT02918279 - Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity Phase 3
Completed NCT00978393 - A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers Phase 1
Completed NCT03661879 - Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity Phase 1
Completed NCT05024032 - A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN) Phase 3
Completed NCT02568306 - A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects Phase 1
Completed NCT00781937 - Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance Phase 3
Completed NCT03223493 - Awareness, Care & Treatment in Obesity Management (ACTION) Study
Completed NCT03308721 - Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity Phase 1
Completed NCT02941042 - A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity. Phase 1
Completed NCT02453711 - Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus Phase 2
Completed NCT02527200 - Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome Phase 3
Completed NCT02958085 - Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight Phase 1
Terminated NCT00665665 - Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers Phase 1
Completed NCT04156165 - The Effect of High vs. Moderate Protein Consumption on Human Health N/A
Recruiting NCT03669809 - The Biological Rhythm of Human Metabolite
Completed NCT02079870 - Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo Phase 1
Completed NCT03095807 - Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity Phase 1
Recruiting NCT05785221 - Lifestyle Intervention on Metabolic Homeostasis N/A